共 16 条
[1]
Association of outcomewith early stroke treatment:pooled analysis of ATLANTIS,E-CASS,and NINDS rt-PA stroke trials. Hacke W,Donnan G,Fieschi C,et al. The Lancet . 2004
[2]
Convertingtissueplasminogenactivatortoazymogen: aregulatorytriadofAspHisSer. MadisonEL,KobeA,GethingMJ, etal. Science . 1993
[3]
Nonproteolyticneuroprotectionbyhumanrecombinanttissueplasminogenactivator. KimYH,ParkJH,HongSH, etal. Science . 1999
[4]
Nonproteolyticneuroprotectionbyhumanrecombinanttissueplasminogenactivator. KimYH,ParkJH,HongSH, etal. Science . 1999
[5]
Vampire bat salivary plasminogen activator (desmoteplase) a unique fibrinolytic enzyme that does not promote neurodegenera -tion. Liberatore GT,Samson A,Bladin C,et al. Stroke . 2003
[6]
Neuroserpin: aselectiveinhibitoroftissue typeplasminogenactivatorinthecentralnervoussystem. YepesM,LawrenceDA. Thrombosis and Haemostasis . 2004
[7]
Thecontributionofprotease activatedreceptor1toneuronaldamagecausedbytransientfocalcerebralischemia. JungeCE,SugawaraT,MannaioniG, etal. Proceedings of the National Academy of Sciences of the United States of America . 2003
[8]
Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Qian Z,Gilbert ME,Colicos MA, et al. Nature . 1993
[9]
Emerging Therapies for Acute Ischemic Stroke New Therapies on Trial. Fisher M,Brott TG. Stroke . 2003
[10]
Acute Stroke Therapy by In-hibition of Neutrophils(ASTIN):an adaptive dose-response study of UK-279,276in acute ischemic stroke. Krams M,Lees KR,Hacke W,et al. Stroke . 2003